https://www.iba-radiopharmasolutions.com/en/discover-and-learn/development-nh3-ammonia-target-cyclone-30-kfshrc
Development of [NH3] Ammonia target for Cyclone-30 at KFSH&RC | IBA Radiopharma
https://www.iba-radiopharmasolutions.com/en/discover-and-learn/users-voice-adam-dabkowski-petic
User's voice Adam Dabkowski from PETIC | IBA Radiopharma
uservoiceadamibaradiopharma
https://www.iba-radiopharmasolutions.com/en/discover-and-learn/users-voice-sebastien-hanard-about-iba-services-and-upgrades
User's voice Sebastien Hanard about IBA services and upgrades | IBA Radiopharma
about ibauservoicesebastien
https://www.iba-radiopharmasolutions.com/en/discover-and-learn/fully-automated-synthesis-18f-fet-using-synthera-platform
Fully automated synthesis of 18F-FET using the Synthera Platform | IBA Radiopharma
fully automated
https://www.iba-radiopharmasolutions.com/en/discover-and-learn/iba-users-meeting-2019
IBA Users Meeting 2019 | IBA Radiopharma
ibausersmeetingradiopharma
https://www.bioworld.com/articles/709355-telix-announces-200m-nasdaq-ipo-to-bolster-radiopharma-pipeline?v=preview
Telix announces $200M Nasdaq IPO to bolster radiopharma pipeline | BioWorld
Australian radiopharmaceutical company Telix Pharmaceuticals Ltd. announced its IPO on the Nasdaq to raise $200 million to advance its late-stage radiopharma...
announcesnasdaqipobolsterradiopharma
https://www.theragnostics.no/en/event/focused_ecosystem_meetingmay2026/
Clinical Infrastructure & Trial Opportunities in the Norwegian Radiopharma & Theranostics Ecosystem...
May 5, 2026 - Norway offers a solid foundation for radiopharmaceutical and theranostics clinical trials, with well-established clinical expertise, access to patients, and...
the norwegianclinicalinfrastructuretrialopportunities
https://glytherix.com/dr-brad-walsh-will-be-presenting-the-glytherix-story-at-radiopharma-day/
Dr Brad Walsh will be presenting the GlyTherix story at Radiopharma Day - GlyTherix
Feb 22, 2024 - Facebook Twitter LinkedIn
brad walsh
https://www.iba-radiopharmasolutions.com/en/discover-and-learn/webinar-innovations-and-future-outlook-radiotheranostics
Webinar Innovations and Future Outlook in Radiotheranostics | IBA Radiopharma
future outlookwebinarinnovationsibaradiopharma
https://mediradiopharma.com/
Home | Medi-Radiopharma - Your Global Nuclear Medicine Supplier
Research, development, manufacture and trade of active radiopharmaceutical ingredients and radiopharmaceuticals. Learn more.
nuclear medicineradiopharmaglobalsupplier
https://www.iba-radiopharmasolutions.com/en/discover-and-learn/brochure-iba-academy
Brochure IBA Academy | IBA Radiopharma
brochureibaacademyradiopharma
https://www.iba-radiopharmasolutions.com/en/discover-and-learn/expert-spotlight-alpha-vs-beta-particles-mechanisms-therapy
Expert Spotlight | Alpha vs. beta particles mechanisms in therapy | IBA Radiopharma
beta particlesexpertspotlightalphavs
https://www.iba-radiopharmasolutions.com/en/get-touch
Get in touch | IBA Radiopharma
get in touchibaradiopharma
https://www.iba-radiopharmasolutions.com/en/our-people
Our people | IBA Radiopharma
our peopleibaradiopharma
https://www.bioworld.com/articles/701505-lilly-enters-radiopharma-space-with-14b-buyout-of-point-biopharma?v=preview
Lilly enters radiopharma space with $1.4B buyout of Point Biopharma | BioWorld
Indianapolis-based Eli Lilly and Co. agreed to acquire Point Biopharma Global Inc. for $12.50 per share in cash, or about $1.4 billion, in a deal that would...